Corning on Pace for Biggest One-Day Drop Since 2002 After Soft Guidance
Corning shares plunge as cautious Q3 outlook overshadows strong Q2 results fueled by generative AI-driven optical demand.
NOTRELOAD AI
Wolfe Research Downgrades Spyre Therapeutics to Peer Perform on Valuation Concerns
Wolfe Research cuts Spyre Therapeutics from Outperform to Peer Perform, citing fair valuation ($96–$113) and weaker Q3 catalysts.
Boeing Turns Positive Free Cash Flow Early, Eyes $1–3 Billion in 2026 as 737 Production Ramps
Boeing posts Q2 loss but turns free cash flow positive earlier than expected. Targets $1–3B FCF in 2026 as 737 production ramps to 47/month.
Altimmune’s Experimental Drug Cuts Heavy Drinking Days in Key Phase 2 Trial
Altimmune’s experimental drug cut heavy drinking and helped weight loss in a mid-stage alcohol use disorder trial. Next: FDA meeting.
AMD Secures Up to 2.5 GW of Data Center Capacity with Core Scientific
Core Scientific Q2 2026: $164.2M total revenue, $136.7M colocation revenue. AMD partnership unlocks up to 2.5GW capacity and $14B potential revenue.
Q2 and Raised Outlook Put PayPal on Firmer Footing—While Keeping Acquisition Options Alive
PayPal outperforms estimates, raises 2026 outlook, and CEO signals openness to M&A if a deal creates superior value versus executing the ongoing transformation strategy.